Investing.com - Xylem (NYSE: XYL) reported third quarter EPS of $1.11, in line with the analyst estimate of $1.11. Revenue for the quarter came in at $2.1B versus the consensus estimate of $2.17B.
Guidance
Xylem sees FY 2024 EPS of $4.22-$4.24 versus the analyst consensus of $4.26.
Xylem sees FY 2024 revenue of $8.50B versus the analyst consensus of $8.58B.
Xylem's stock price closed at $130.22. It is up 0.05% in the last 3 months and up 37.83% in the last 12 months.
Xylem saw 5 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Xylem's stock price’s past reactions to earnings here.
According to InvestingPro, Xylem's Financial Health score is "good performance".
Check out Xylem's recent earnings performance, and Xylem's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar